Bird & Bird advises MaxLinear on the acquisition of Intel’s Home Gateway Platform Division

Bird & Bird LLP advises MaxLinear, Inc., a leading provider of radio frequency (RF), analog and mixed-signal integrated circuits for the connected home, wired and wireless infrastructure, and industrial and multimarket applications, on the acquisition of Intel’s Home Gateway Platform Division assets in an all-cash, asset transaction.

 

The transaction valued at $150 million was signed on 5 April 2020 and the closing is expected in the third quarter of 2020, subject to customary closing conditions, including regulatory approvals.


Intel’s Home Gateway Platform Division comprises Wi-Fi Access Points, Ethernet, and Home Gateway SoC products deployed across operator and retail markets. The acquisition will enable MaxLinear to complement its existing portfolio, bringing together a complete and scalable platform of connectivity and access solutions for its customers across target end-markets, as well as creating potential new revenue opportunities in adjacent target end-markets.


MaxLinear has been advised by the following international Bird & Bird lawyers: lead partners Dr Catharina Klumpp (Employment) and Dr Stefanie Orttmann (Corporate/M&A), associates Daniel Klare and Jan Medele (both Corporate/M&A), Düsseldorf, associate Dr Kathrin Kruse (Employment), Düsseldorf, partner Sandra Seah (Corporate/M&A), Singapore, Counsel Karolina Stawicka (Employment), associate Izabela Staniszewska-Brzozek (Commercial) both Warsaw and partner Anne-Cecile Hansson (Corporate/M&A), Paris.

 

The team acted in cooperation with lead advisor Wilson Sonsini Goodrich Rosati as well as with Austrian law firm Torggler. 

News & Deals

More News & Deals

Deal

Bird & Bird advises World of Women on its transaction to join the Tezos ecosystem

Jul 23 2024

Read More

Deal

Bird & Bird advised EIFFEL GAZ VERT on an investment in the biogas sector

Jul 23 2024

Read More

News

Bird & Bird grows its Finance practice in Italy with the arrival of two new partners

Jul 19 2024

Read More

Deal

Bird & Bird has advised Dopay on its $13.5 million Series A Extension round

Jul 19 2024

Read More

News

Bird & Bird advises iX Biopharma on rights issue

Jul 15 2024

Read More

Deal

Bird & Bird advises HSS on SciRhom’s EUR 63 million Series A financing round

Jul 11 2024

Read More